Gyenno Science

Founded in 2013, Gyenno Science is a leading innovative technology company in neurological disorders, pursuing the vision of "achieving patient benefits through emerging technologies and advancing the development of neurology".

Based on emerging technologies such as artificial intelligence and fusion perception, Gyenno has established 10+ years of deep interdisciplinary collaboration in medicine, engineering and science with universities and experts worldwide, and has co-built the "Intelligent Digital Medical Center for Neurological Disorders" and the "Joint Postgraduate Training Base" with Huazhong University of Science and Technology, building an AI-powered full-time-space medical system in aspects such as diagnostic assessment, innovative therapies and clinical decision-making. Related products have obtained medical device registration certifications in major global regions including China NMPA, US FDA and EU CE.

In China, the company's product technology system has covered 90+% of Parkinson's disease centers and 700+ tertiary hospitals, deeply supporting China's Parkinson's disease specialty construction system and China's Parkinson's disease clinical quality control system, with some technologies incorporated into the "Guidelines for the Treatment of Parkinson's Disease". Globally, it has achieved commercial coverage in 38 countries and regions.

The company has led/participated in 14 national and provincial/municipal research projects, published 40+ high-quality SCI papers (total impact factor ~300), 10 international conference papers, and generated 50+ patents and nearly 50 software copyrights. It has successively received multiple honors including CB Insights Global Digital Health 150 and Deloitte China Life Sciences & Health Care Rising Star 50.

Representative innovative technologies for Parkinson's disease and movement disorders:
GYENNO Intelligence
A medical artificial intelligence system integrating large models, deep learning, classical machine learning and other technologies, learning knowledge and experience and mining data patterns, running through full-time-space scenarios inside and outside hospitals with different embodied carriers.

MATRIX Series
Empowered by GYENNO Intelligence, it achieves complete motor function and motor symptom quantitative assessment, intelligent scale scoring, disease classification analysis and early probability calculation for neurological disorders.

BRAVO Series
Utilizing wearable perception and GYENNO Intelligence to quantitatively analyze hand motor symptoms, and driving active assistive technology to achieve eating assistance.

SKYWALK Series
Utilizing wearable perception and GYENNO Intelligence to dynamically predict and identify freezing of gait, and helping patients restore normal walking through personalized non-invasive neuromodulation technology.

HYPNOS Series
Utilizing contact-based perception and GYENNO Intelligence, it automatically analyzes nighttime symptoms and sleep quality of Parkinson's disease patients based on signals such as BCG and body movement.

REALM Series
Empowered by GYENNO Intelligence, it provides structured storage, management and intelligent analysis of multimodal clinical data, and establishes digital workflows and clinical quality control systems for specialty centers.

PD CARE Series
Empowered by GYENNO Intelligence and integrated with the REALM Series and innovative medical devices, it achieves patient self-management and doctor proactive management based on its own internet hospital, operational services and innovative technologies.

AI Remote Follow-up Series
Empowered by GYENNO Intelligence and combined with digital technology and audio-video channels, it helps doctors effectively grasp symptom changes of patients outside hospitals and supports personalized treatment decisions throughout the full course of disease.

AI Speech Rehabilitation Series
Empowered by GYENNO Intelligence and utilizing digital interaction technology, combined with the full-time-space diagnosis and treatment ecosystem, it provides patients with convenient and efficient home-based interactive speech rehabilitation solutions.